The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma
NCT ID: NCT00792337
Last Updated: 2013-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
53 participants
INTERVENTIONAL
2008-12-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
simvastatin
simvastatin in combination with budesonide
simvastatin
10 mg per oral once daily for 8 weeks
B1-6-12
Budesonide in combination with B1-6-12
B1-6-12
1 table per day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
simvastatin
10 mg per oral once daily for 8 weeks
B1-6-12
1 table per day for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* He or she requires less than 1000 mcg daily of beclomethasone or equivalent
Exclusion Criteria
* He or she had previous history of liver disease
* She is pregnant or during lactation
* He or she has already received statins or is allergic to statins or has developed myositis.
* He or she has an asthma exacerbation and requires treatment with oral corticosteroids during the 3 months prior to the commencement of study entry.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mahidol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kittipong Maneechotesuwan
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kittipong - Maneechotesuwan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Siriraj Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kittipong Maneechotesuwan
Bangkoknoi, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
004(II)/51
Identifier Type: -
Identifier Source: org_study_id